Theravance Biopharma Revenue (TTM) Trends

Theravance Biopharma Inc (TBPH)

9.19 -0.02 (-0.22%) USD | NASDAQ | Apr 19, 12:11

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	57.42M
September 30, 2023	54.51M
June 30, 2023	51.27M
March 31, 2023	48.57M
December 31, 2022	51.35M
September 30, 2022	51.64M
June 30, 2022	52.39M
March 31, 2022	54.25M
December 31, 2021	55.31M
September 30, 2021	59.10M
June 30, 2021	64.16M
March 31, 2021	66.25M
December 31, 2020	71.86M
September 30, 2020	82.63M
June 30, 2020	76.80M
March 31, 2020	87.94M
December 31, 2019	73.41M
September 30, 2019	59.65M
June 30, 2019	60.06M
March 31, 2019	57.39M
December 31, 2018	60.37M

Date	Value
September 30, 2018	49.15M
June 30, 2018	40.58M
March 31, 2018	20.62M
December 31, 2017	15.39M
September 30, 2017	16.56M
June 30, 2017	31.36M
March 31, 2017	33.32M
December 31, 2016	48.65M
September 30, 2016	46.85M
June 30, 2016	38.47M
March 31, 2016	40.14M
December 31, 2015	42.13M
September 30, 2015	39.67M
June 30, 2015	35.30M
March 31, 2015	31.14M
December 31, 2014	11.69M
September 30, 2014	10.43M
June 30, 2014	4.118M
March 31, 2014	1.149M
December 31, 2013	0.226M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

48.57M

Minimum

Mar 2023

87.94M

Maximum

Mar 2020

62.03M

Average

59.10M

Median

Sep 2021

Revenue (TTM) Benchmarks